3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
CA 2492427 A1 · Owner: Carry, Jean-Christophe · Inventors: Kleemann, Heinz-Werner; Ronan, Baptiste; Desmazeau, Pascal
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to 3-guanidinocarbonyl-1-heteroaryl-indole derivatives of the formula (I) in which R1 to R5 and Ar have the meaning stated in the claims. The inventive compounds are suitable for example as antiarrhytmic medicaments with cardioprotective component for infarction prophylaxis and infarction treatment and for the treatment of angina pectoris. They also inhibit in a preventive manner the pathophysiological processes associated with the development of ischemia-induced damage in particular in , the triggering of ischemia-induced cardiac arrhytmias and of heart failure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 2, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.